Back to www.texasliver.org
____________________________________________________________________________________
Current Studies
Currently Recruiting for the Following Studies. Call 832-355-8966 to see if you qualify. Free standard of care (physician, nurses, drug(s))
- PBC (Primary biliary cirrhosis)
Modified bile acid (INT-747 study drug) for subjects currently taking URSO
- PBC (Primary biliary cirrhosis)
Modified bile acid (INT-747 study drug) for subjects not taking URSO
- Hepatitis C
For Naïve or non-responders
- Hepatitis C
Effect of treatment with Pegasys® / Copegus® with or without concomitantpioglitazone (Actos®) on early viral kineticsin treatment-naïve patients with chronic hepatitis C (genotype 1 HCV infection) and insulin resistance)
- Autoimmune Hepatitis
Study of LCP - Tacro Tablets vs. Azathioprine, in combination with corticosteriods, for the treatment of Autoimmune Hepatitis
- Hepatic Encephalopathy
Comparison of Difference Regimens in Patients with Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose
- Coming soon - hepatitis B trial for people who have never been treated!
- Numerous other studies coming soon. Check back often.
Advanced Liver Therapies
6620 Main Street, Suite 1505 · Houston, TX 77030
P 832-355-8966 · F 832-355-8965
http://www.sleh.com
alt@sleh.com